Abstract:Introduction Patients with heart failure and preserved ejection fraction (HFpEF) are frequently associated with atrial fibrillation (AF), and such clinical condition has worse clinical status than those with sinus rhythm. Whether the use of a strategy to maintain sinus rhythm in patients with HFpEF would affect outcomes remains uncertain. Purpose To investigate whether the strategy of AF ablation to maintain sinus rhythm compared to no ablation is associated with improvement of all-cause death and rehospitalization for worsening heart failure in patients with AF and HFpEF. Methods In this retrospective cohort study, a total of 1034 patients with HFpEF and AF (69 [63, 76] years, 478 [46.2%] female) were analyzed, 392 patients who received first-time AF ablation were assigned to the ablation group, and the remaining 642 patients with merely medical therapy were assigned to the no ablation group. The primary end point was a composite of all-cause mortality or rehospitalization for worsening heart failure and was assessed by the Kaplan-Meier method and Cox proportional hazard model. Baseline differences were adjusted by multivariable-adjustment analysis, propensity score-matched analysis, and inverse probability of treatment weighting analysis. Atrial tachycardia/AF recurrence was assessed in a multivariable-adjusted Fine & Gray model, with death treated as a competing risk factor. Results After a median follow-up period of 39 months, the cumulative incidence of the primary end point was significantly lower in the ablation group compared to the no ablation group after multivariable adjustment in the overall cohort (adjusted hazard ratio [HR], 0.65 [95% CI, 0.45-0.94], P = 0.02; incidence rate difference [IRD], -0.39 [95% CI, -0.54 to -0.25]). Analyses for secondary outcomes revealed that clinical benefit produced by AF ablation was mainly driven by rehospitalization for worsening heart failure (adjusted HR, 0.65 [95% CI, 0.44-0.96], P = 0.03) with an estimated IRD of -0.31 (95% CI, -0.45 to -0.18). Results were consistent in the propensity score-matched analysis and inverse probability of treatment weighting analysis. In addition, patients in the ablation group had a 34% relative decrease in the atrial tachycardia/AF recurrence (adjusted HR, 0.66 [95% CI, 0.55-0.81], P < 0.001) relative to no ablation group in the multivariate-adjusted Fine & Gray model. Patients who received AF ablation and maintained sinus rhythm during the follow-up period had a lower risk of the primary end point (P < 0.001 by log-rank test). Conclusion(s) Among HFpEF and AF patients, the strategy of AF ablation to maintain sinus rhythm led to a lower risk of the composite of death from any cause or hospitalization for worsening heart failure.Figure 1.Kaplan–Meier curvesTable 1.Incidence rate and hazard ratio

Relationship between amiodarone response prior to ablation and 1-year outcomes of catheter ablation for atrial fibrillation

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Oral Amiodarone In Blank Period Affects Mmp-9 And Timp-1 Level In Post-Ablation Paroxymal Atrial Fibrillation Patients

Clinical outcome of left atrial ablation for paroxysmal atrial fibrillation is related to the extent of radiofrequency ablation

Ablation for Atrial Fibrillation Improves the Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: a Single-Center Cohort Study

Long-term Outcomes of Catheter Ablation of Atrial Fibrillation in Dilated Cardiomyopathy

Catheter Ablation Of Non-Paroxysmal Atrial Fibrillation Using Sinus Rhythm Defragmentation Plus Low Voltage Zone Homogenization After Pulmonary Vein Isolation: 30 Months' Outcome From Nonrandomized Comparison With Stepwise Approach

Surgical ablation for atrial fibrillation: risk factors for recurrence and long-term outcome

Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden

Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of life

Optimal Rhythm-Control Strategy for Recurrent Atrial Tachycardia after Catheter Ablation of Persistent Atrial Fibrillation: a Randomized Clinical Trial

Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation.

A review regarding the article 'Multidisciplinary management strategies for atrial fibrillation.'

Incremental Efficacy for Repeat Ablation Procedures for Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up

Long-term outcomes of catheter ablation of atrial fibrillation post-cardiac valve replacement.

Effectiveness of a Triple Antiarrhythmic Drug Strategy for Arrhythmia Recurrence after Persistent Atrial Fibrillation Ablation.

Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study

Predictors for recurrent atrial tachyarrhythmia after ablation for patients with persistent atrial fibrillation:A long-term follow-up outcome

Pharmacological therapy following catheter ablation of atrial fibrillation

Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes

Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis.